Autek China Inc.

Shenzhen Stock Exchange 300595.SZ

Autek China Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 17.37%

Autek China Inc. Return on Capital Employed (ROCE) is 17.37% for the year ending December 31, 2023, a 3.41% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Autek China Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 16.80%, a -35.10% change year over year.
  • Autek China Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 25.88%, a 26.83% change year over year.
  • Autek China Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 20.41%, a -11.55% change year over year.
  • Autek China Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 23.07%, a 1.71% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300595.SZ

Autek China Inc.

CEO Mr. Yuequn Tao
IPO Date Jan. 18, 2017
Location China
Headquarters No. 4899 Wangjiang West Road
Employees 3,229
Sector Consumer Discretionary
Industries
Description

Autek China Inc. engages in the research, development, production, and sale of eye vision and related supporting products. It offers optometry medical devices, such as orthokeratology lenses for vision correction and myopia control. The company was founded in 2001 and is based in Hefei, China.

Similar companies

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 3.70

NA

300015.SZ

Aier Eye Hospital Group Co., Ltd.

USD 1.70

NA

600763.SS

Topchoice Medical Corporation

USD 5.65

NA

300760.SZ

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

USD 32.04

NA

StockViz Staff

February 1, 2025

Any question? Send us an email